The investigation determined that reproducible, lower than expected vitros crea results were obtained from a single patient sample when processed on a vitros 5600 integrated system, when compared to the result obtained from a non-vitros roche method.The investigation was unable to determine a definitive assignable cause.However, since the issue was isolated to a single patient sample, an unknown sample interferent that affects the vitros assay, but not the non-vitros roche method, is the likely cause of the event, but this could not be confirmed.There was no indication the vitros 5600 integrated system malfunctioned, however, since no within-run precision performance testing was processed, an instrument related issue cannot be completely ruled out as contributing to the event.Additionally, the historical quality control data review indicates the vitros crea slides were performing as intended and did not likely contribute to the event.A definitive assignable cause for the event could not be determined.
|
A customer obtained reproducible, lower than expected vitros creatinine (crea) results from a single patient sample tested on a vitros 5600 integrated system, when compared to the result obtained from a non-vitros roche method.Vitros crea results of 0.56 and 0.46 mg/dl vs.The expected result of 3.45 mg/dl.Biased results of the magnitude and direction observed may lead to inappropriate physician action if the event were to occur undetected.The lower than expected crea results were not reported outside the laboratory and there were no reported allegations of actual patient harm as a result of this event.This report corresponds to ortho clinical diagnostics (ortho) inc.Complaint numbers (b)(4) / qerts record id (b)(4).
|